Treat Stroke to Target: Lower LDL-C target better for subsequent stroke prevention
02 Mar 2020
byJairia Dela Cruz
Patients with atherosclerotic disease who have had an ischaemic stroke or transient ischaemic attack (TIA) may fare better with a lower low-density lipoprotein cholesterol (LDL-C) target, as reducing LDL-C levels even below the 90–110 mg/dL target range at <70 mg/dL confers superior protection against the risk of subsequent stroke, according to data from the Treat Stroke to Target trial.
